SCHEMBL13436331

SCHEMBL13436331

CCN1CCN(c2cncc(C(C)C)c2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.46
GAA P10253 2/20 0.46
RAD52 P43351 2/20 0.46
MAPT P10636 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
GFER P55789 2/20 0.46
CHRNA7 P36544 1/20 0.45
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
KDM2B Q8NHM5 2/20 0.38
ALDH1A1 P00352 2/20 0.37
LMNA P02545 1/20 0.37
TSHR P16473 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
CCR6 P51684 1/20 0.36
SIGMAR1 Q99720 1/20 0.36
KHK P50053 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13436338 0.88 DRD2 (0.47) KDM4EGAAKDM2BCCR6SIGMAR1
SCHEMBL13436327 0.86 ALDH1A1 (0.41) KDM4EMAPTGFERALDH1A1LMNA
SCHEMBL13436339 0.85 DRD2 (0.44) KDM4EGAASIGMAR1
SCHEMBL15871366 0.85 ALDH1A1 (0.40) KDM4EMAPTGFERALDH1A1LMNA
SCHEMBL13436276 0.84 ALDH1A1 (0.43) KDM4EMAPTSMN1; SMN2ALDH1A1LMNA
SCHEMBL15871373 0.84 TGFBR1 (0.43) KDM4EMAPTGFERALDH1A1LMNA
SCHEMBL13436329 0.82 KDM2B (0.44) KDM2BHRH3
SCHEMBL13436264 0.82 OPRD1 (0.36) MAPTALDH1A1LMNATSHRCCR6
SCHEMBL13436269 0.82 CCR6 (0.36) KDM4EMAPTGFERALDH1A1LMNA
SCHEMBL13436337 0.82 HRH3 (0.36) KDM4ELMNAHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8778929-B2 Substituted heteroaryl inhibitors of B-RAF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-07-15 US disclosed
US-8778929-B2 Substituted heteroaryl inhibitors of B-RAF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-07-15 US disclosed
US-20110312939-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-12-22 US disclosed
US-20110312939-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-12-22 US disclosed
WO-2010034838-A2 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-04-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110312939-A1 NEW CHEMICAL COMPOUNDS CCNA1, CCNT1, MKI67 KDM4E 2715/4885GAA 716/4885RAD52 4247/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.